![](/img/cover-not-exists.png)
Phase II Trial of Natalizumab (Tysabri®) with Corticosteroids as Initial Treatment of Gastrointestinal Acute Graft Versus Host Disease
Kekre, Natasha, Kim, Haesook T., Ho, Vincent T., Guo, Yikun, Mahmood, Umair, Belatreche, Wafae, Koreth, John, Armand, Philippe, Nikiforow, Sarah, Alyea, Edwin P., Nageshwar, Prashant, Glotzbecker, BreVolume:
24
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2017.12.649
Date:
March, 2018
File:
PDF, 82 KB
english, 2018